Portal de Periódicos da CAPES

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials

1999; Wiley; Volume: 46; Issue: 1 Linguagem: Inglês

10.1002/1531-8249(199907)46

1531-8249

Donald E. Goodkin, Stephen C. Reingold, W. A. Sibley, J. S. Wolinsky, H. McFarland, Diane L. Cookfair, Fred Lublin,

Peripheral Neuropathies and Disorders

Annals of NeurologyVolume 46, Issue 1 p. 132-134 Special Report Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials D. E. Goodkin MD, Corresponding Author D. E. Goodkin MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorS. Reingold PhD, S. Reingold PhD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorW. Sibley MD, W. Sibley MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorJ. Wolinsky MD, J. Wolinsky MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorH. McFarland MD, H. McFarland MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorD. Cookfair PhD, D. Cookfair PhD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorF. Lublin MD, F. Lublin MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorNational Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis , National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis F. Lublin (Chair), Philadelphia, PA; M. Clanet, Toulouse, France; D. Cookfair, Buffalo, NY; G. Ebers, London, Ontario, Canada; D. Goodkin, San Francisco, CA; H. P. Hartung, Graz, Austria; R. Lisak, Detroit, MI; W. I. McDonald, London, UK; H. McFarland, Bethesda, MD; J. Noseworthy, Rochester, MN; H. Panitch, Baltimore, MD; C. Polman, Amsterdam, The Netherlands; A. Reder, Chicago, IL; P. Rudge, London, UK; W. Sibley, Tucson, AZ; J. Whitaker, Birmingham, AL; and J. Wolinsky, Houston, TX.Search for more papers by this author D. E. Goodkin MD, Corresponding Author D. E. Goodkin MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorS. Reingold PhD, S. Reingold PhD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorW. Sibley MD, W. Sibley MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorJ. Wolinsky MD, J. Wolinsky MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorH. McFarland MD, H. McFarland MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorD. Cookfair PhD, D. Cookfair PhD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorF. Lublin MD, F. Lublin MD UCSF/MT Zion Multiple Sclerosis Center, 1600 Divisidero St, San Francisco, CA 95115Search for more papers by this authorNational Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis , National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis F. Lublin (Chair), Philadelphia, PA; M. Clanet, Toulouse, France; D. Cookfair, Buffalo, NY; G. Ebers, London, Ontario, Canada; D. Goodkin, San Francisco, CA; H. P. Hartung, Graz, Austria; R. Lisak, Detroit, MI; W. I. McDonald, London, UK; H. McFarland, Bethesda, MD; J. Noseworthy, Rochester, MN; H. Panitch, Baltimore, MD; C. Polman, Amsterdam, The Netherlands; A. Reder, Chicago, IL; P. Rudge, London, UK; W. Sibley, Tucson, AZ; J. Whitaker, Birmingham, AL; and J. Wolinsky, Houston, TX.Search for more papers by this author First published: 22 May 2001 https://doi.org/10.1002/1531-8249(199907)46:1 3.0.CO;2-ZCitations: 8 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume46, Issue1July 1999Pages 132-134 RelatedInformation